Molecular dynamics of insulin/IGF‐I receptor transmembrane signaling

To examine the molecular basis of ligand‐stimulated intramolecular β‐subunit autophosphorylation, hybrid receptors composed of wild‐type and mutantinsulin and insulin‐like growth factor‐1 (lGF‐l) half‐receptor precursors were characterized. Previous studies have demonstrated that assembly of the IGF‐I wild‐type half‐receptor (αβWT) with a kinase‐defective half‐receptor (αβA/K) produced a substrate kinase‐inactive holoreceptor in vitro [Treadway et al. (1991): Proc Natl Acad Sci USA 88:214–218]. To extend these studies, the vaccinia virus/ bacteriophage T7 expression system was used to generate various hybrid receptor complexes in cultured cells. As was observed for hybrid receptors assembled in vitro, the wild‐type/mutant hybrid receptors formed in situ were also incapable of phosphorylating several peptide substrates. However, ligand‐stimulated β‐subunit autophosphorylation was still observed. To determine the molecular basis for this discrepancy, hybrid receptors were assembled from a truncated β‐subunit insulin half‐receptor (αβδ43). and a kinase‐defective half‐receptor (αβA/K). Under these conditions, insulin‐stimulated autophosphorylation primarily oc‐curred on the full‐length kinase‐inactive β‐subunit (αβA/K) without significant labeling of the kinase‐active truncated β‐subunit (αβδ43). A similar IGF‐I hybrid receptor species was characterized, and the same pattern of autophosphorylation was observed in response to IGF‐I. These data demonstrate that both insulin and IGF‐I stimulate an intramolecular trans‐autophosphorylation reaction between two adjacent β‐subunits within the holoreceptors. Furthermore, our data suggest that trans‐phosphorylation between two functional β‐subunits is required for substrate kinase activation of the insulin and IGF‐I holoreceptors. These results suggest a molecular basis for the dominant‐negative phenotype observed in heterozygous, insulin‐resistant patients possessing one kinase‐defective insulin receptor allele. © 1993 Wiley‐Liss, Inc.

[1]  J. Treadway,et al.  Transmembrane signaling by the human insulin receptor kinase. Relationship between intramolecular beta subunit trans- and cis-autophosphorylation and substrate kinase activation. , 1992, The Journal of biological chemistry.

[2]  J. Flier,et al.  Lilly Lecture: Syndromes of Insulin Resistance: From Patient to Gene and Back Again , 1992, Diabetes.

[3]  D. Accili,et al.  Mutations in the insulin receptor gene. , 1992, Endocrine reviews.

[4]  R. Garofalo,et al.  Functional and immunological distinction between insulin-like growth factor I receptor subtypes in KB cells. , 1992, The Journal of biological chemistry.

[5]  S. O’Rahilly,et al.  Mutant insulin receptors in syndromes of insulin resistance , 1992, Clinical endocrinology.

[6]  J. Treadway,et al.  Insulin/IGF‐1 hybrid receptors: Implications for the dominant‐negative phenotype in syndromes of insulin resistance , 1992, Journal of cellular biochemistry.

[7]  O. Rosen,et al.  The role of insulin receptor autophosphorylation in signal transduction. , 1991, The Journal of biological chemistry.

[8]  J. Tavaré,et al.  Evidence for hybrid rodent and human insulin receptors in transfected cells. , 1991, The Journal of biological chemistry.

[9]  J. Olefsky,et al.  Mutation of the two carboxyl-terminal tyrosines results in an insulin receptor with normal metabolic signaling but enhanced mitogenic signaling properties. , 1991, The Journal of biological chemistry.

[10]  O. Elroy-Stein,et al.  New mammalian expression vectors , 1990, Nature.

[11]  A. Ullrich,et al.  Receptors for insulin and insulin-like growth factor-I can form hybrid dimers. Characterisation of hybrid receptors in transfected cells. , 1990, The Biochemical journal.

[12]  K. Siddle,et al.  Hybrid Insulin Receptors: Molecular Mechanisms of Negative-Dominant Mutations in Receptor-Mediated Insulin Resistance , 1990, Diabetes Care.

[13]  M. Lane,et al.  Substrate phosphorylation catalyzed by the insulin receptor tyrosine kinase. Kinetic correlation to autophosphorylation of specific sites in the beta subunit. , 1989, The Journal of biological chemistry.

[14]  K. Siddle,et al.  Immunological relationships between receptors for insulin and insulin-like growth factor I. Evidence for structural heterogeneity of insulin-like growth factor I receptors involving hybrids with insulin receptors. , 1989, The Biochemical journal.

[15]  V. Duronio,et al.  Insulin-like growth factor I receptor beta-subunit heterogeneity. Evidence for hybrid tetramers composed of insulin-like growth factor I and insulin receptor heterodimers. , 1989, The Journal of biological chemistry.

[16]  A. Ullrich,et al.  Mutation of the insulin receptor at tyrosine 960 inhibits signal transmission but does not affect its tyrosine kinase activity , 1988, Cell.

[17]  W. Rutter,et al.  Expression and characterization of a functional human insulin-like growth factor I receptor. , 1988, The Journal of biological chemistry.

[18]  K. Siddle,et al.  Analysis of insulin-receptor phosphorylation sites in intact cells by two-dimensional phosphopeptide mapping. , 1988, The Biochemical journal.

[19]  A. Ullrich,et al.  Properties of a human insulin receptor with a COOH-terminal truncation. II. Truncated receptors have normal kinase activity but are defective in signaling metabolic effects. , 1988, The Journal of biological chemistry.

[20]  D. Leroith,et al.  Insulin-like growth factor I receptors on mouse neuroblastoma cells. Two beta subunits are derived from differences in glycosylation. , 1988, European journal of biochemistry.

[21]  J. Tavaré,et al.  Studies on the autophosphorylation of the insulin receptor from human placenta. Analysis of the sites phosphorylated by two-dimensional peptide mapping. , 1988, The Biochemical journal.

[22]  P. Pilch,et al.  Ligand-dependent intersubunit association within the insulin receptor complex activates its intrinsic kinase activity. , 1988, The Journal of biological chemistry.

[23]  C. Kahn,et al.  A cascade of tyrosine autophosphorylation in the beta-subunit activates the phosphotransferase of the insulin receptor. , 1988, The Journal of biological chemistry.

[24]  J. Avruch,et al.  Identification of the insulin receptor tyrosine residues undergoing insulin-stimulated phosphorylation in intact rat hepatoma cells. , 1988, The Journal of biological chemistry.

[25]  J. Avruch,et al.  Identification of insulin receptor tyrosine residues autophosphorylated in vitro. , 1987, The Journal of biological chemistry.

[26]  C Collins,et al.  Insulin‐like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. , 1986, The EMBO journal.

[27]  M. Czech,et al.  Tyrosine phosphorylation of insulin receptor beta subunit activates the receptor tyrosine kinase in intact H-35 hepatoma cells. , 1986, The Journal of biological chemistry.

[28]  H. Klein,et al.  Insulin activation of insulin receptor tyrosine kinase in intact rat adipocytes. An in vitro system to measure histone kinase activity of insulin receptors activated in vivo. , 1986, The Journal of biological chemistry.

[29]  M. Lane,et al.  Kinetic evidence for activating and non-activating components of autophosphorylation of the insulin receptor protein kinase. , 1986, Biochemical and biophysical research communications.

[30]  J. Pessin,et al.  Incorporation of the purified human placental insulin receptor into phospholipid vesicles. , 1985, Biochemistry.

[31]  K. Jarnagin,et al.  The human insulin receptor cDNA: The structural basis for hormone-activated transmembrane signalling , 1985, Cell.

[32]  P. H. Seeburg,et al.  Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes , 1985, Nature.

[33]  O. Rosen,et al.  Insulin receptor is an insulin-dependent tyrosine protein kinase: copurification of insulin-binding activity and protein kinase activity to homogeneity from human placenta. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[34]  C. Kahn,et al.  Kinetic properties and sites of autophosphorylation of the partially purified insulin receptor from hepatoma cells. , 1984, The Journal of biological chemistry.

[35]  P. Pilch,et al.  The insulin receptor protein kinase. Physicochemical requirements for activity. , 1983, The Journal of biological chemistry.

[36]  M. Cobb,et al.  Phosphorylation activates the insulin receptor tyrosine protein kinase. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[37]  M. Rechler,et al.  The nature and regulation of the receptors for insulin-like growth factors. , 1985, Annual review of physiology.

[38]  M. Czech The nature and regulation of the insulin receptor: structure and function. , 1985, Annual review of physiology.